U.S. Food and Staples Retail Stock News

Redaptive previously announced the completion of the first phase of a multi-site energy modernization program with UniFirst, upgrading LED lighting across 39 U.S. facilities covering more than 2.5 million square feet and aiming to cut energy use and emissions over the coming decade. This program is projected to save UniFirst several million dollars in energy costs while avoiding over 21,000 metric tons of CO2 emissions, underscoring how operational efficiency and sustainability initiatives...

In recent days, CRISPR Therapeutics has drawn attention as a pre-arranged share sale by CEO Samarth Kulkarni coincided with fresh commentary on its development pipeline and upcoming earnings expectations. At the same time, investor focus has intensified on the early commercial rollout of Casgevy, the company’s lead gene-edited therapy, as a potential long-term growth driver despite near-term earnings pressure. We’ll now examine how the CEO’s planned share sale and Casgevy’s commercial...

Columbia Banking System (COLB) has wrapped up FY 2025 with fourth quarter revenue of US$694 million and basic EPS of US$0.73, alongside trailing twelve month revenue of about US$2.2 billion and EPS of US$2.31. These results put fresh numbers on the table for investors watching its profitability story. Over recent periods, the company has seen revenue move from US$458.9 million in Q4 2024 to US$694 million in Q4 2025, while EPS shifted from US$0.69 to US$0.73. This sets the backdrop for how...

Earlier this week, law firm Johnson Fistel, PLLP announced it is investigating whether Merchants Bancorp or its executives violated federal securities laws by misrepresenting or withholding material information from investors, with a focus on potential loss recovery. The probe highlights growing legal and governance scrutiny around Merchants Bancorp’s disclosures, potentially influencing how investors assess the bank’s transparency and risk profile. We’ll now examine how this securities...

GSK has signed a definitive agreement to acquire RAPT Therapeutics (NasdaqGM:RAPT). The deal centers on ozureprubart, a long acting anti-IgE antibody in Phase IIb trials for food allergy prophylaxis. The transaction brings a food allergy candidate into GSK’s immunology and inflammation portfolio. RAPT Therapeutics, trading at $57.63, has recently seen very large 1 year returns and strong short term moves, with the share price up 64.2% over the past week and 60.8% over the past month. Year...

Northern Trust FY 2025 Earnings Snapshot Northern Trust (NTRS) just wrapped up FY 2025 with fourth quarter total revenue of US$2,131.1 million and basic EPS of US$2.41, alongside net income excluding extra items of US$452.3 million. The company has seen quarterly revenue move from US$1,970.1 million in Q4 2024 to US$2,131.1 million in Q4 2025. Over that same period, basic EPS shifted from US$2.27 to US$2.41 on a quarterly basis and from US$9.80 to US$8.78 on a trailing twelve month basis,...

S&P Global’s Board of Directors recently approved a 1.0% increase in its regular quarterly cash dividend, lifting the payout from US$0.96 to US$0.97 per share, payable on March 11, 2026 to shareholders of record on February 25, 2026, and raising the annualized dividend rate to US$3.88 per share. The modest dividend increase, which reflects the expected 2026 spin-off of S&P Global’s Mobility division, comes alongside reports highlighting the company’s long dividend-growth record and its...

If you are wondering whether Pinnacle Financial Partners at around US$97 a share looks like an opportunity or a value trap, you are in the right place. The stock has seen mixed returns, with a 1 year decline of 20.5% and a 5 year return of 49.2%. This can change how the market is thinking about both risk and long term potential. Recent coverage of regional banks and shifting sentiment toward the sector has kept investors focused on balance sheet resilience, loan quality and capital strength...

Playtika Holding Corp. recently announced a cost-cutting drive that will eliminate about 15% of its workforce, roughly 500 roles, as it shifts from large teams to leaner groups powered by artificial intelligence and automation. The company plans to reinvest the savings from these layoffs into growth initiatives aimed at sharpening its competitive position in the mobile games market, highlighting how efficiency and innovation are becoming more closely linked in the sector. Next, we will...

Bitmine Immersion Technologies (BMNR) just secured shareholder approval to lift its authorized share count to 50,000,000,000, a material shift that gives the crypto focused firm significantly more room to issue equity. See our latest analysis for Bitmine Immersion Technologies. Those new share authorizations land at a tense moment for the stock, with the latest 90 day share price return of a 42.87% decline and shorter term weakness contrasting with a very large 1 year total shareholder...

Why Flutter Entertainment’s boardroom and regulatory news matters for shareholders Flutter Entertainment (FLUT) has been under pressure recently, with the stock down about 20% over the past month and roughly 28% over the past 3 months, against a backdrop of changing analyst sentiment. Several banks and brokers have reassessed their views, with a string of downgrades and lower price targets highlighting concerns around short term headwinds. At the same time, UK regulatory developments and a...

Why Consolidated Edison is back in focus ahead of Q4 earnings Consolidated Edison (ED) is back under the spotlight as it prepares to report fiscal Q4 2025 results on February 19, alongside recently raised full year adjusted EPS guidance and mixed analyst sentiment. See our latest analysis for Consolidated Edison. The current share price of $103.87 sits alongside a 30 day share price return of 4.36% and a 90 day share price return of 3.83%. The 1 year total shareholder return of 18.60% and 5...

Recently, analysts revisited Viper Energy’s prospects, offering a mix of optimistic and cautious views as the company continues expanding its mineral and royalty interests in the Permian Basin. This renewed analyst attention highlights how expectations around future cash flows and growth are influencing how investors frame Viper Energy’s business model today. Against this backdrop of shifting analyst opinions, we’ll explore what these reassessments could mean for Viper Energy’s broader...

In recent weeks, Strategy Inc. (formerly MicroStrategy) raised more than US$2.13 billion through common and perpetual preferred stock sales to buy 22,305 bitcoin, lifting its corporate holdings to 709,715 coins and further cementing its role as a proxy for bitcoin exposure. This push has shifted its balance sheet toward perpetual preferred equity instead of convertible debt, easing refinancing deadlines but heightening focus on ongoing dividend obligations and the long‑term sustainability of...

A whistleblower has alleged that a Wynn Resorts nightlife executive accepted millions of dollars in kickbacks from liquor companies and distributors over several years, prompting the company to hire an outside law firm to investigate potential felony and federal alcohol regulation violations. The claims that senior leaders may have been aware of the alleged scheme raise questions about internal controls and oversight across Wynn Resorts’ operations. Next, we’ll examine how these...

Booking Holdings (BKNG) is back in focus as traders look ahead to its upcoming fourth quarter and full year 2025 earnings release, along with renewed interest in its expanded Booking.com integration with corporate travel platform Navan. See our latest analysis for Booking Holdings. The recent Navan integration and upcoming earnings call come against a mixed share price backdrop, with a 6.39% 1 month share price return decline contrasting with a 7.80% 1 year total shareholder return and a very...

Why Ultragenyx Pharmaceutical Is Back on Investors’ Radar Ultragenyx Pharmaceutical (RARE) has drawn fresh attention after raising its 2025 revenue guidance to an estimated US$672 million to US$674 million, which the company says sits above its prior range. The updated outlook, pointing to roughly 20% projected growth versus 2024, gives investors a new reference point for thinking about the business and how the current share price reflects those expectations. See our latest analysis for...

Ionis Pharmaceuticals and Otsuka Pharmaceutical recently secured European Commission approval for DAWNZERA™ (donidalorsen), the first RNA-targeted, self-administered therapy to prevent recurrent hereditary angioedema attacks in adults and adolescents aged 12 and older across the EU. This decision extends the commercial reach of Ionis’s antisense technology beyond the U.S., adding a new royalty and milestone stream tied to European HAE patients. We’ll now examine how European approval of...

Why SLB Stock Is Back on Investor Radars SLB (SLB) has caught investor attention after a strong recent run, with the share price up about 29% over the past month and roughly 37% in the past 3 months. This move comes alongside reported annual revenue of US$36.2b and net income of US$3.4b. These figures give you a starting point to think about how the current US$49.15 share price lines up with the underlying business. See our latest analysis for SLB. Beyond the recent jump, SLB’s 30 day share...

This piece is designed to help you assess for yourself whether Bank of America stock still offers value at today's price, or if most of the opportunity is already priced in. Bank of America shares last closed at US$51.72, with returns of a 2.4% decline over 7 days, an 8.1% decline over 30 days, a 7.6% decline year to date, and a 13.8% gain over 1 year, 57.8% over 3 years, and 96.8% over 5 years. Recent headlines have focused on Bank of America as one of the major US banks at the center of...

What Dropbox’s Recent Returns Suggest About Investor Sentiment Dropbox (DBX) has drawn attention after a mixed run in its share price, with a small gain over the past week contrasted with weaker returns over the past month and past 3 months. See our latest analysis for Dropbox. Looking past the recent pullback, Dropbox’s 1 year total shareholder return of 16.45% contrasts with a 6.41% 1 month share price decline. This suggests momentum has cooled as investors reassess growth prospects and...

If you are wondering whether Par Pacific Holdings is still attractively priced after a strong run, this article walks through the numbers in a clear, practical way. The stock trades at US$35.21 after a 4.5% decline over the last week and a 1.7% decline year to date, even though the 1 year return sits at 101.2% and the 5 year return at 165.1%. Recent coverage has focused on how Par Pacific fits into the broader US energy sector and how investors are reassessing refinery and logistics...

Qualcomm is contending with Apple shifting to in house 5G modems, which could pressure its core handset modem business. The broader mobile handset market is under pressure, adding another challenge for Qualcomm's traditional revenue base. At the same time, Qualcomm is leaning into growth areas such as Automotive and IoT and has launched new AI chips. The company has recently acquired a business to expand its presence in data center markets. QUALCOMM, ticker NasdaqGS:QCOM, sits at the center...

If you are wondering whether TE Connectivity's current share price matches its underlying worth, you are not alone. This article walks through what the numbers are really saying about the stock. TE Connectivity's shares last closed at US$223.84, with returns of 47.0% over 1 year, 87.8% over 3 years and 101.6% over 5 years. This comes even as the stock has seen a 7.1% decline over the past week, a 3.5% decline over the past month, and is down 4.0% year to date. Recent prices sit against a...